2025-10-20 - Analysis Report
Okay, here's an analysis of Lam Research Corp. (LRCX) based on the data you provided. I'll present the key figures first, followed by a more detailed breakdown and analysis.

**Executive Summary:**

*   **LRCX significantly outperformed the S&P 500 (VOO) historically.** The cumulative return difference is substantial (139.6%), placing LRCX in the upper range of its historical outperformance relative to the S&P 500.
*   **Recent price action shows a slight pullback**, but the stock is trading above its short-term and long-term moving averages.
*   **Market Risk Indicator suggests Low Investment.** Hybrid signal recommends reducing holdings.
*   **Analyst sentiment is generally positive (Buy)**, but the current price is trading above the average target price.
*   **Revenue and Profitability are increasing.**
*   **The recent news is mixed, with positive articles.**

---

**1. Performance vs. S&P 500 (VOO):**

*   **Ticker:** LRCX (Lam Research Corp) - *A global supplier of wafer fabrication equipment and services to the semiconductor industry.*
*   **LRCX Cumulative Return:** 236.68%
*   **VOO Cumulative Return:** 97.05%
*   **Outperformance (Absolute):** 139.6%
*   **Outperformance (Relative):** 90.8% (This means LRCX's current outperformance is near the high end of its historical range compared to VOO)
*   **Outperformance Range:** Max: 155.3, Min: -15.5

**Analysis:** Lam Research has historically delivered substantially higher returns than the S&P 500. The significant positive relative divergence indicates that LRCX is performing exceptionally well compared to the benchmark. However, it's important to note that high relative divergence can also indicate a potential for mean reversion.

**Alpha, Beta Analysis Table:**

| Year       | CAGR     | MDD      | Alpha   | Beta   | Cap(B) |
|------------|----------|----------|---------|--------|--------|
| 2015-2017  | 84.0%    | 67.8%    | 56.0%   | 0.0    | 23.2   |
| 2016-2018  | 18.0%    | 68.1%    | 3.0%    | 0.1    | 17.2   |
| 2017-2019  | 53.0%    | 82.9%    | 31.0%   | 1.2    | 36.9   |
| 2018-2020  | 66.0%    | 82.9%    | 42.0%   | 1.1    | 59.5   |
| 2019-2021  | 119.0%   | 82.9%    | 73.0%   | 1.0    | 90.7   |
| 2020-2022  | -10.0%   | 79.2%    | -9.0%   | 0.9    | 53.0   |
| 2021-2023  | -13.0%   | 80.4%    | -15.0%  | 1.0    | 98.8   |
| 2022-2024  | -52.0%   | 80.4%    | -72.0%  | 1.0    | 91.1   |
| 2023-2025  | 148.0%   | 80.4%    | 86.0%   | 0.9    | 178.4  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) demonstrates significant volatility over the years, with both substantial gains (e.g., 148.0% in 2023-2025) and losses (e.g., -52.0% in 2022-2024).
*   **MDD:** The Maximum Drawdown (MDD) values are consistently high, indicating substantial risk and volatility.
*   **Alpha:** The Alpha values fluctuate significantly, showing periods of strong outperformance and underperformance relative to the benchmark. Recent years show impressive alpha, especially in 2023-2025.
*   **Beta:** The Beta values are generally around 1, suggesting that LRCX's price tends to move in tandem with the market.

**2. Recent Price Action:**

*   **Current Price:** 141.51
*   **Previous Close:** 142.41
*   **Change:** -0.63
*   **5-day Moving Average:** 140.96
*   **20-day Moving Average:** 137.55
*   **60-day Moving Average:** 115.36

**Analysis:** The price has slightly decreased compared to the previous close. However, the fact that the current price is above all three moving averages (5, 20, and 60-day) suggests an upward trend. The 5-day moving average being above the 20-day moving average further reinforces this short-term bullish momentum.

**3. Technical Indicators & Risk Assessment:**

*   **Market Risk Indicator (MRI):** 0.5 (Low Investment Recommended)
*   **RSI:** 58.79
*   **PPO:** -0.83
*   **Hybrid Signal:** Cash_80%_Sell 80.0% of holdings (2491 shares - Risky - MRI:0.50) (Cash Ratio: 80% on 2025-10-16)
*   **Delta Previous Relative Divergence:** 12.3 (+) (Short-term increase)
*   **Expected Return (%):** 17.6%

**Analysis:** The MRI suggests a low investment recommendation. The RSI of 58.79 indicates that the stock is neither overbought nor oversold. PPO suggests that the price might be in a short-term correction. However, The positive change in relative divergence indicates improving short-term performance compared to the S&P 500. The "Hybrid Signal" suggests reducing holdings, driven by the moderate risk assessment. The 17.6% expected return indicates potential outperformance relative to the S&P 500 for long-term investors.

**4. Recent News & Significant Events:**

*   **[2025-10-19]** Tesla, Netflix set to report earnings as US-China trade fight turns 'unsustainable': What to watch this week (Yahoo Finance)
*   **[2025-10-18]** Is Lam Research’s Rally Justified After AI Chip Surge and Strong 2025 Momentum? (Simply Wall St.)
*   **[2025-10-17]** Tesla Stock Holds Near Highs Ahead Of Q3 Results; Netflix, Intel, IBM Also Due (Investor's Business Daily)
*   **[2025-10-17]** 1 Tech Stock to Buy Before the End of 2025 (Motley Fool)
*   **[2025-10-17]** The Zacks Analyst Blog Highlights NVIDIA, Roche, Lam Research, Tredegar and Kewaunee Scientific (Zacks)

**Analysis:** The news articles provide a mixed picture. A recent article highlights the company's strong momentum related to the AI chip surge. Other articles also mention Lam Research as a potentially attractive tech stock.

**4-2. Analyst Opinions:**

*   **Consensus:** Buy
*   **Mean Rating:** 1.74 (Buy)
*   **Opinions:** 30
*   **Target Price (Avg/High/Low):** 128.49 / 175.00 / 80.00

**Analysis:** Analyst sentiment is generally positive, with a "Buy" consensus. However, the average target price is *below* the current market price, suggesting that analysts may believe the stock is currently overvalued or that future growth is already priced in.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-04-25 | 1.04 | 4.72 B$   |
| 2025-01-31 | 0.93 | 4.38 B$   |
| 2024-10-28 | 0.86 | 4.17 B$   |
| 2024-01-29 | 7.25 | 3.76 B$   |
| 2025-01-31 | 0.72 | 3.76 B$   |

**Analysis:** Recent EPS and revenue figures show growth in general.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-06-30   | $5.17B   | 50.08%        |
| 2025-03-31   | $4.72B   | 49.02%        |
| 2024-12-31   | $4.38B   | 47.37%        |
| 2024-09-30   | $4.17B   | 48.05%        |
| 2024-06-30   | $3.87B   | 47.53%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE    |
|--------------|----------|--------|
| 2025-06-30   | $9.86B   | 17.44% |
| 2025-03-31   | $9.51B   | 13.99% |
| 2024-12-31   | $8.81B   | 13.52% |
| 2024-09-30   | $8.47B   | 13.18% |
| 2024-06-30   | $8.54B   | 11.95% |

**Analysis:** Revenue and profit margins are generally increasing. Equity is also growing, along with a rising Return on Equity (ROE), indicating improved profitability in relation to shareholder equity.

**7. Overall Analysis & Summary:**

Lam Research (LRCX) presents a mixed picture based on the provided data:

*   **Strengths:**
    *   Strong historical outperformance relative to the S&P 500.
    *   Positive short-term price momentum.
    *   Increasing revenue, profit margins, and ROE.
    *   Favorable news articles highlighting the company's role in the AI chip market.
    *   Positive analyst consensus ("Buy").
*   **Weaknesses/Concerns:**
    *   Relatively high MDD that indicates substantial risk and volatility
    *   The Hybrid Signal recommends reducing holdings based on its risk assessment.
    *   Analysts' average target price is below the current market price.

**Recommendation:**

Given the mixed signals, a cautious approach is warranted. The company has a strong history and positive momentum, but the current valuation and risk indicators suggest it may not be the best time to significantly increase exposure. Investors might consider holding their current positions, or even trimming them slightly, as suggested by the Hybrid Signal. Monitoring future earnings reports and any changes in analyst sentiment will be crucial for making informed decisions.
